Health In Tech, Inc. (HIT) Income Statement
HIT 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsHIT revenue and net income
Where HIT's revenue goes
2025Each bar shows an amount and its share of revenue. HIT kept 3.8% of revenue as net income.
HIT profit margins
HIT growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +71.0% | +79.4% | — | — |
| Gross profit | +35.6% | +56.8% | — | — |
| Operating income | +54.4% | +95.2% | — | — |
| Net income | +90.7% | +152.2% | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HIT quarterly EPS vs estimates
Health In Tech beat the analyst EPS estimate in 4 of the last 6 quarters. Next report: November 9, 2026 (estimate $-0.06).
HIT income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $33.3M | $19.5M | $19.2M | $5.8M |
| Cost of revenue | $12.4M | $4.1M | $2.3M | $334,188 |
| Gross profit | $20.9M | $15.4M | $16.8M | $5.4M |
| Research & development | $1.6M | $2.8M | $2.0M | $794,617 |
| Sales, general & admin | $17.8M | $11.6M | $11.5M | $4.4M |
| Total operating expenses | $19.4M | $14.4M | $13.5M | $5.2M |
| Operating income | $1.5M | $989,904 | $3.4M | $205,582 |
| Interest income | $409,922 | $122,885 | $40,857 | $0 |
| Interest expense | $0 | $495,000 | $2,052 | $4,572 |
| Income before taxes | $1.7M | $889,000 | $3.4M | $201,010 |
| Income taxes | $395,330 | $218,523 | $945,236 | $121,268 |
| Net income | $1.3M | $670,477 | $2.5M | $79,742 |
| EBITDA | $2.6M | $1.9M | $3.8M | $205,582 |
| EPS (diluted) | $0.02 | −$0.01 | $0.05 | — |
| Gross margin | 62.8% | 79.2% | 88.0% | 94.2% |
| Operating margin | 4.6% | 5.1% | 17.7% | 3.6% |
| Net margin | 3.8% | 3.4% | 12.9% | 1.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.8M | $7.5M | $8.5M | $9.3M | $8.0M | $4.9M | $4.5M | $5.0M | $5.1M | $5.2M | $5.2M |
| Cost of revenue | $4.1M | $4.3M | $3.4M | $3.3M | $3.0M | $2.7M | $1.1M | $979,628 | $974,727 | $989,911 | $951,967 | $855,234 |
| Gross profit | $3.9M | $4.5M | $4.1M | $5.1M | $6.3M | $5.4M | $3.8M | $3.5M | $4.0M | $4.1M | $4.3M | $4.4M |
| Research & development | $875,811 | $920,395 | $213,113 | $235,819 | $582,609 | $537,721 | $633,653 | $718,424 | $701,626 | $760,196 | $673,444 | $501,121 |
| Sales, general & admin | $6.5M | $5.7M | $4.1M | $4.4M | $5.0M | $4.3M | $3.5M | $2.3M | $2.8M | $3.0M | $2.1M | $3.4M |
| Total operating expenses | $7.4M | $6.7M | $4.3M | $4.7M | $5.6M | $4.9M | $4.1M | $3.0M | $3.5M | $3.8M | $2.8M | $3.9M |
| Operating income | −$3.4M | −$2.2M | −$170,813 | $493,523 | $725,070 | $480,658 | −$316,336 | $438,882 | $534,936 | $332,422 | $1.5M | $518,141 |
| Interest income | $69,568 | $67,471 | $104,659 | $111,699 | $108,198 | $85,366 | $28,774 | $38,460 | $31,339 | $24,312 | $26,132 | $14,479 |
| Interest expense | — | — | $0 | $0 | $0 | $0 | $0 | $165,000 | $165,000 | $165,000 | $1,104 | $0 |
| Income before taxes | −$3.3M | −$2.1M | −$443,741 | $600,222 | $833,268 | $684,423 | −$110,748 | $406,739 | $401,275 | $191,734 | $1.5M | $532,620 |
| Income taxes | −$809,888 | −$480,069 | −$141,184 | $148,046 | $202,637 | $185,831 | $33,404 | $30,653 | $63,268 | $91,198 | $478,113 | $130,225 |
| Net income | −$2.5M | −$1.6M | −$302,557 | $452,176 | $630,631 | $498,592 | −$144,152 | $376,086 | $338,007 | $100,536 | $1.0M | $402,395 |
| EBITDA | −$3.2M | −$1.7M | −$33,111 | $818,203 | $969,251 | $820,406 | $25,235 | $707,323 | $701,062 | $491,521 | $1.6M | $657,341 |
| EPS (diluted) | −$0.04 | −$0.03 | −$0.01 | $0.01 | $0.01 | $0.01 | −$0.01 | — | — | — | — | — |
| Gross margin | 48.7% | 51.4% | 55.0% | 60.6% | 67.7% | 66.8% | 77.4% | 78.0% | 80.5% | 80.7% | 81.8% | 83.7% |
| Operating margin | −42.7% | −24.6% | −2.3% | 5.8% | 7.8% | 6.0% | −6.4% | 9.8% | 10.7% | 6.5% | 27.9% | 9.9% |
| Net margin | −31.2% | −18.1% | −4.0% | 5.3% | 6.8% | 6.2% | −2.9% | 8.4% | 6.8% | 2.0% | 19.2% | 7.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HIT's financial statements (latest annual report filed March 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HIT financial results
In fiscal year 2025 (ended December 31, 2025), Health In Tech reported revenue of $33.3 million, up 71.0% from the year before. It had net income of $1.3 million (up 90.7%), a net profit margin of 3.8%. Diluted earnings per share came to $0.02.
See the HIT stock overview for the latest quote and news, or the HIT chart for price history and technical indicators.
HIT income statement FAQ
What is Health In Tech's annual revenue?
Health In Tech reported total revenue of $33.3 million for fiscal year 2025, which ended on December 31, 2025. That was up 71.0% from $19.5 million the previous year.
Is Health In Tech profitable?
Yes. Health In Tech reported net income of $1.3 million in fiscal 2025, a net profit margin of 3.8%; its operating margin was 4.6%.
What is Health In Tech's gross margin?
Health In Tech's gross margin was 62.8% in fiscal 2025: for every $100 of revenue, Health In Tech kept $63 after the direct cost of its products and services.
How much does Health In Tech spend on research and development?
Health In Tech spent $1.6 million on research and development in fiscal 2025, 4.7% of revenue.
What are Health In Tech's earnings per share?
Health In Tech earned $0.02 per diluted share in fiscal 2025, compared with $-0.01 a year earlier.
When will Health In Tech report its next earnings?
Health In Tech is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.
When does Health In Tech's fiscal year end?
Health In Tech's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 25, 2026.